Progress in endocrine therapy for breast carcinoma
1998; Wiley; Volume: 83; Issue: 1 Linguagem: Inglês
10.1002/(sici)1097-0142(19980701)83
ISSN1097-0142
Autores Tópico(s)HER2/EGFR in Cancer Research
ResumoAn increased understanding of the mechanism of action of steroid hormonal agents has transformed clinicians' ability to identify hormone-sensitive breast carcinoma. Furthermore, a new generation of hormonal agents has replaced the major surgical ablative procedures and the original additive hormonal agents used in the past.
Referência(s)